Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 117.943
Filtrer
1.
Biomaterials ; 312: 122739, 2025 Jan.
Article de Anglais | MEDLINE | ID: mdl-39096840

RÉSUMÉ

The biofilm-induced "relatively immune-compromised zone" creates an immunosuppressive microenvironment that is a significant contributor to refractory infections in orthopedic endophytes. Consequently, the manipulation of immune cells to co-inhibit or co-activate signaling represents a crucial strategy for the management of biofilm. This study reports the incorporation of Mn2+ into mesoporous dopamine nanoparticles (Mnp) containing the stimulator of interferon genes (STING) pathway activator cGAMP (Mncp), and outer wrapping by M1-like macrophage cell membrane (m-Mncp). The cell membrane enhances the material's targeting ability for biofilm, allowing it to accumulate locally at the infectious focus. Furthermore, m-Mncp mechanically disrupts the biofilm through photothermal therapy and induces antigen exposure through photodynamic therapy-generated reactive oxygen species (ROS). Importantly, the modulation of immunosuppression and immune activation results in the augmentation of antigen-presenting cells (APCs) and the commencement of antigen presentation, thereby inducing biofilm-specific humoral immunity and memory responses. Additionally, this approach effectively suppresses the activation of myeloid-derived suppressor cells (MDSCs) while simultaneously boosting the activity of T cells. Our study showcases the efficacy of utilizing m-Mncp immunotherapy in conjunction with photothermal and photodynamic therapy to effectively mitigate residual and recurrent infections following the extraction of infected implants. As such, this research presents a viable alternative to traditional antibiotic treatments for biofilm that are challenging to manage.


Sujet(s)
Biofilms , Indoles , Protéines membranaires , Polymères , Biofilms/effets des médicaments et des substances chimiques , Polymères/composition chimique , Animaux , Indoles/composition chimique , Indoles/pharmacologie , Souris , Protéines membranaires/métabolisme , Nanoparticules/composition chimique , Photothérapie dynamique/méthodes , Porosité , Macrophages/métabolisme , Macrophages/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Femelle , Transduction du signal/effets des médicaments et des substances chimiques , Thérapie photothermique , Cellules myéloïdes suppressives/métabolisme , Cellules myéloïdes suppressives/effets des médicaments et des substances chimiques , Souris de lignée C57BL
2.
Clin Chim Acta ; 564: 119906, 2025 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-39127296

RÉSUMÉ

Mycoplasma pneumoniae can cause respiratory infections and pneumonia, posing a serious threat to the health of children and adolescents. Early diagnosis of Mycoplasma pneumoniae infection is crucial for clinical treatment. Currently, diagnostic methods for Mycoplasma pneumoniae infection include pathogen detection, molecular biology techniques, and bacterial culture, all of which have certain limitations. Here, we developed a rapid, simple, and accurate detection method for Mycoplasma pneumoniae that does not rely on large equipment or complex operations. This technology combines the CRISPR-Cas12a system with recombinase polymerase amplification (RPA), allowing the detection results to be observed through fluorescence curves and immunochromatographic lateral flow strips.It has been validated that RPA-CRISPR/Cas12a fluorescence analysis and RPA-CRISPR/Cas12-immunochromatographic exhibit no cross-reactivity with other common pathogens, and The established detection limit was ascertained to be as low as 102 copies/µL.Additionally, 49 clinical samples were tested and compared with fluorescence quantitative polymerase chain reaction, demonstrating a sensitivity and specificity of 100%. This platform exhibits promising clinical performance and holds significant potential for clinical application, particularly in settings with limited resources, such as clinical care points or resource-constrained areas.


Sujet(s)
Systèmes CRISPR-Cas , Mycoplasma pneumoniae , Mycoplasma pneumoniae/génétique , Mycoplasma pneumoniae/isolement et purification , Humains , Systèmes CRISPR-Cas/génétique , Techniques d'amplification d'acides nucléiques/méthodes , Pneumopathie à mycoplasmes/diagnostic , Pneumopathie à mycoplasmes/microbiologie
3.
Biomaterials ; 312: 122721, 2025 Jan.
Article de Anglais | MEDLINE | ID: mdl-39106817

RÉSUMÉ

Silver nanoparticles (AgNPs) are a potential antiviral agent due to their ability to disrupt the viral particle or alter the virus metabolism inside the host cell. In vitro, AgNPs exhibit antiviral activity against the most common human respiratory viruses. However, their capacity to modulate immune responses during respiratory viral infections has yet to be explored. This study demonstrates that administering AgNPs directly into the lungs prior to infection can reduce viral loads and therefore virus-induced cytokines in mice infected with influenza virus or murine pneumonia virus. The prophylactic effect was diminished in mice with depleted lymphoid cells. We showed that AgNPs-treatment resulted in the recruitment and activation of lymphocytes in the lungs, particularly natural killer (NK) cells. Mechanistically, AgNPs enhanced the ability of alveolar macrophages to promote both NK cell migration and IFN-γ production. By contrast, following infection, in mice treated with AgNPs, NK cells exhibited decreased activation, indicating that these nanoparticles can regulate the potentially deleterious activation of these cells. Overall, the data suggest that AgNPs may possess prophylactic antiviral properties by recruiting and controlling the activation of lymphoid cells through interaction with alveolar macrophages.


Sujet(s)
Cellules tueuses naturelles , Poumon , Nanoparticules métalliques , Infections à Orthomyxoviridae , Argent , Animaux , Argent/composition chimique , Argent/pharmacologie , Nanoparticules métalliques/composition chimique , Poumon/virologie , Poumon/anatomopathologie , Poumon/effets des médicaments et des substances chimiques , Infections à Orthomyxoviridae/prévention et contrôle , Infections à Orthomyxoviridae/traitement médicamenteux , Infections à Orthomyxoviridae/virologie , Souris , Cellules tueuses naturelles/effets des médicaments et des substances chimiques , Macrophages alvéolaires/effets des médicaments et des substances chimiques , Macrophages alvéolaires/métabolisme , Macrophages alvéolaires/virologie , Souris de lignée C57BL , Lymphocytes/effets des médicaments et des substances chimiques , Lymphocytes/métabolisme , Antiviraux/pharmacologie , Antiviraux/usage thérapeutique , Femelle , Activation des lymphocytes/effets des médicaments et des substances chimiques
4.
Methods Mol Biol ; 2854: 199-212, 2025.
Article de Anglais | MEDLINE | ID: mdl-39192131

RÉSUMÉ

Antiviral innate immunity plays a critical role in the defense against viral infections, yet its complex interactions with viruses have been challenging to study using traditional models. Organoids, three-dimensional (3D) tissue-like structures derived from stem cells, have emerged as powerful tools for modeling human tissues and studying the complex interactions between viruses and the host innate immune system. This chapter summarizes relevant applications of organoids in antiviral innate immunity studies and provides detailed information and experimental procedures for using organoids to study antiviral innate immunity.


Sujet(s)
Immunité innée , Organoïdes , Maladies virales , Organoïdes/immunologie , Organoïdes/virologie , Humains , Maladies virales/immunologie , Maladies virales/virologie , Animaux , Interactions hôte-pathogène/immunologie , Virus/immunologie
5.
Methods Mol Biol ; 2854: 221-236, 2025.
Article de Anglais | MEDLINE | ID: mdl-39192133

RÉSUMÉ

Zebrafish is a widely used model organism in genetics, developmental biology, pathology, and immunology research. Due to their fast reproduction, large numbers, transparent early embryos, and high genetic conservation with the human genome, zebrafish have been used as a model for studying human and fish viral diseases. In particular, the ability to easily perform forward and reverse genetics and lacking a functional adaptive immune response during the early period of development establish the zebrafish as a favored option to assess the functional implication of specific genes in the antiviral innate immune response and the pathogenesis of viral diseases. In this chapter, we detail protocols for the antiviral innate immunity analysis using the zebrafish model, including the generation of gene-overexpression zebrafish, generation of gene-knockout zebrafish by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology, methods of viral infection in zebrafish larvae, analyzing the expression of antiviral genes in zebrafish larvae using qRT-PCR, Western blotting and transcriptome sequencing, and in vivo antiviral assays. These experimental protocols provide effective references for studying the antiviral immune response in the zebrafish model.


Sujet(s)
Systèmes CRISPR-Cas , Modèles animaux de maladie humaine , Immunité innée , Danio zébré , Animaux , Danio zébré/immunologie , Danio zébré/génétique , Danio zébré/virologie , Immunité innée/génétique , Maladies virales/immunologie , Maladies virales/génétique , Techniques de knock-out de gènes , Animal génétiquement modifié
6.
Methods Mol Biol ; 2854: 237-251, 2025.
Article de Anglais | MEDLINE | ID: mdl-39192134

RÉSUMÉ

The innate immune system is the first line of host defense against infection by pathogenic microorganisms, among which macrophages are important innate immune cells. Macrophages are widely distributed throughout the body and recognize and eliminate viruses through pattern recognition receptors (PRRs) to sense pathogen-associated molecular patterns (PAMPs). In the present chapter, we provide detailed protocols for vesicular stomatitis virus (VSV) amplification, VSV titer detection, isolation of mouse primary peritoneal macrophages, in vitro and in vivo VSV infection, detection of interferon-beta (IFN-ß) expression, and lung injury. These protocols provide efficient and typical methods to evaluate virus-induced innate immunity in vitro and in vivo.


Sujet(s)
Immunité innée , Interféron bêta , Macrophages péritonéaux , Vesiculovirus , Animaux , Souris , Macrophages péritonéaux/immunologie , Macrophages péritonéaux/virologie , Macrophages péritonéaux/métabolisme , Interféron bêta/immunologie , Interféron bêta/métabolisme , Interféron bêta/génétique , Vesiculovirus/immunologie , Vesiculovirus/génétique , Stomatite vésiculeuse/immunologie , Stomatite vésiculeuse/virologie , Virus de la stomatite vésiculeuse de type Indiana/immunologie , Récepteurs de reconnaissance de motifs moléculaires/métabolisme , Récepteurs de reconnaissance de motifs moléculaires/immunologie
7.
World J Surg ; 2024 Sep 09.
Article de Anglais | MEDLINE | ID: mdl-39252147
8.
Int J Med Sci ; 21(11): 2109-2118, 2024.
Article de Anglais | MEDLINE | ID: mdl-39239537

RÉSUMÉ

Background: Sodium‒glucose cotransporter-2 (SGLT2) inhibitors offer glycaemic and cardiorenal benefits in the early stage of chronic kidney disease (CKD). However, the use of SGLT2 inhibitors may increase the risk of genitourinary tract infection (GUTI). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may also cause deterioration of kidney function. The long-term follow-up of cardiorenal outcomes and GUTI incidence in patients with advanced CKD receiving SGLT2 inhibitors combined with ACEIs/ARBs should be further investigated. Methods: We analysed data from 5,503 patients in Taiwan's Taipei Medical University Research Database (2016-2020) who were part of a pre-end-stage renal disease (ESRD) program (CKD stages 3-5) and received ACEIs/ARBs. SGLT2 inhibitor users were matched 1:4 with nonusers on the basis of sex, CKD, and program entry duration. Results: The final cohort included 205 SGLT2 inhibitor users and 820 nonusers. SGLT2 inhibitor users experienced a significant reduction in ESRD/dialysis risk (aHR = 0.35, 95% CI = 0.190.67), and SGLT2 inhibitor use was not significantly associated with acute kidney injury or acute kidney disease risk. Among SGLT2 inhibitor users, those with a history of cardiovascular disease (CVD) had greater CVD rates. Conversely, those without a CVD history had lower rates of congestive heart failure, arrhythmia, acute pulmonary oedema, and acute myocardial infarction, although the differences were not statistically significant. Notably, SGLT2 inhibitor usage was associated with a greater GUTI incidence (aHR = 1.78, 95% CI = 1.122.84) shortly after initiation, irrespective of prior GUTI history status. Conclusion: Among patients with CKD stages 3-5, SGLT2 inhibitor use was linked to increased GUTI incidence, but it also significantly reduced the ESRD/dialysis risk without an episodic AKI or AKD risk. Clinical physicians should consider a personalized medicine approach by balancing GUTI episodes and cardiorenal outcomes for advanced CKD patients receiving SGLT2 inhibitors.


Sujet(s)
Antagonistes des récepteurs aux angiotensines , Inhibiteurs de l'enzyme de conversion de l'angiotensine , Insuffisance rénale chronique , Inhibiteurs du cotransporteur sodium-glucose de type 2 , Humains , Inhibiteurs du cotransporteur sodium-glucose de type 2/effets indésirables , Inhibiteurs du cotransporteur sodium-glucose de type 2/usage thérapeutique , Taïwan/épidémiologie , Mâle , Femelle , Adulte d'âge moyen , Études rétrospectives , Incidence , Sujet âgé , Antagonistes des récepteurs aux angiotensines/effets indésirables , Antagonistes des récepteurs aux angiotensines/usage thérapeutique , Insuffisance rénale chronique/épidémiologie , Insuffisance rénale chronique/complications , Inhibiteurs de l'enzyme de conversion de l'angiotensine/effets indésirables , Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique , Diabète de type 2/traitement médicamenteux , Diabète de type 2/complications , Diabète de type 2/épidémiologie
9.
BMC Vet Res ; 20(1): 402, 2024 Sep 09.
Article de Anglais | MEDLINE | ID: mdl-39245726

RÉSUMÉ

BACKGROUND: Trypanosomiasis is an infectious disease caused by parasitic protozoa of the genus Trypanosome and primarily transmitted by tsetse flies. This study aimed to determine the density of tsetse flies and the rate of trypanosome infection in the Bedele and Dabo Hana districts of the Buno Bedele Zone in Ethiopia. RESULTS: A cross-sectional study was conducted from January to February 2023 to catch tsetse flies, determine tsetse density, and estimate the trypanosome infection rate. We used 100 traps (40 NGU, 30 pyramidal, and 30 biconical) to catch the flies. The following standard procedures were followed to identify the specific trypanosome species in the collected tsetse flies: The flies were dissected, and the salivary glands were removed. We placed the salivary glands in a drop of saline solution on a microscope slide. A coverslip was placed over the salivary glands, the slide was examined under a microscope, and the trypanosomes were identified based on their morphology. A total of 3,740 tsetse flies were captured from 100 traps, resulting in an overall apparent density of 18.7 flies per trap per day. Within the study area, only one species of tsetse fly, Glossina tachinoides, was identified. Of the 1,320 dissected Glossina tachinoides, 1.82% were found to be infected with trypanosome parasites. Among these infections, 58.33% were attributed to Trypanosoma congolense, while the remaining 41.67% were caused by Trypanosoma brucei. The infection rate of trypanosomes was significantly higher in female tsetse flies (87.5%) as compared to male flies (12.5%). Furthermore, a significantly higher infection rate was observed in flies older than 20 days (83.33%) and in hunger stage 1 flies (58.33%) compared to hunger stages 2, 3, and 4. CONCLUSIONS: This study highlights the necessity of implementing control and suppression measures targeting the vector (tsetse flies) and the parasite (trypanosomes) to effectively manage and prevent pathogenic animal trypanosomiasis.


Sujet(s)
Trypanosoma , Mouches tsé-tsé , Animaux , Mouches tsé-tsé/parasitologie , Éthiopie/épidémiologie , Femelle , Mâle , Trypanosoma/isolement et purification , Trypanosoma/classification , Études transversales , Densité de population , Trypanosomiase/médecine vétérinaire , Trypanosomiase/épidémiologie , Trypanosomiase/parasitologie , Vecteurs insectes/parasitologie
10.
J Med Primatol ; 53(5): e12733, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39245886

RÉSUMÉ

An adult female rhesus macaque presented during routine annual physical examination for evaluation of a 2.5-cm diameter superficial ulcerated dermal lesion that was subsequently diagnosed as a systemic fungal infection caused by Cryptococcus gattii. Cryptococcus gattii is one of several basidiomycetic yeasts responsible for pulmonary, neurologic, and disseminated infections in humans and animals. This report describes the diagnosis, management, and clinical resolution of a C. gattii infection in an immunocompetent 5-year-old female rhesus macaque.


Sujet(s)
Antifongiques , Cryptococcose , Cryptococcus gattii , Macaca mulatta , Maladies des singes , Animaux , Cryptococcus gattii/isolement et purification , Cryptococcose/médecine vétérinaire , Cryptococcose/traitement médicamenteux , Cryptococcose/diagnostic , Cryptococcose/microbiologie , Femelle , Maladies des singes/microbiologie , Maladies des singes/diagnostic , Maladies des singes/traitement médicamenteux , Antifongiques/usage thérapeutique , Immunocompétence
11.
Eur Urol Focus ; 2024 Sep 06.
Article de Anglais | MEDLINE | ID: mdl-39244510

RÉSUMÉ

Bacteria develop biofilms for protection and persistent colonization. Biofilms of pathogenic bacteria can lead to serious medical problems. Bacterial biofilms on catheters used in the treatment of urinary tract diseases represent a major challenge for antibiotic therapy. Several attempts to eradicate biofilms using classical antibiotics and various alternatives, including antibiotic treatment of surfaces, surfaces that release silver ions, and surfaces with anti-adhesive properties, have not shown clinical efficacy in biofilm prevention or removal. Pseudomonas aeruginosa is one of the most problematic biofilm-forming uropathogens and accounts for approximately 10% of urinary tract infections. Novel glycomimetics that inhibit bacterial lectins have shown promising results in the prevention of P. aeruginosa biofilms and in interference with bacterial virulence. This mini-review summarizes the status of glycomimetic development and provides a perspective on their use in clinical practice. PATIENT SUMMARY: For patients with recurrent urinary tract infections and patients needing long-term catheter use to manage urinary problems, biofilms formed by bacteria can be a problem and are difficult to treat. New compounds that mimic carbohydrates, called glycomimetics, have shown promise in inhibiting these bacteria and the biofilms they form. More research on these compounds is needed before they can be used to treat patients.

12.
Infect Chemother ; 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-39231503

RÉSUMÉ

With advancements in antiretroviral therapy (ART), the average lifespan of people with human immunodeficiency virus (HIV) is increasing, as is the number of older adults with HIV. Accordingly, the number of patients with HIV who undergo surgery or require critical care for various reasons is increasing. Since the prognosis of people with HIV depends on the continuous and effective maintenance of ART, there is a need to consider effectively maintaining ART in people with HIV in these conditions. This case involved a 55-year-old patient with well-controlled HIV who received ART and presented to the emergency room with acute abdominal pain. He was diagnosed with extensive bowel infarction and panperitonitis and received critical care in the intensive care unit, including mechanical ventilation and continuous renal replacement therapy. The patient was administered enteral nutrition via a nasogastric tube. The patient subsequently underwent extensive small bowel resection and developed short bowel syndrome. The patient maintained ART during that period. A literature review related to the use of ART under these conditions is included in this study. This case was discussed at the [Exploring Difficult Cases in HIV Clinics] of the Korean Society for AIDS Conference held in 2023.

13.
Sci Rep ; 14(1): 20625, 2024 09 04.
Article de Anglais | MEDLINE | ID: mdl-39232051

RÉSUMÉ

Improved understanding of mosquito-plant feeding interactions can reveal insights into the ecological dynamics of pathogen transmission. In wild malaria vectors Anopheles gambiae s.l. and An. funestus group surveyed in selected dryland ecosystems of Kenya, we found a low level of plant feeding (2.8%) using biochemical cold anthrone test but uncovered 14-fold (41%) higher rate via DNA barcoding targeting the chloroplast rbcL gene. Plasmodium falciparum positivity was associated with either reduced or increased total sugar levels and varied by mosquito species. Gut analysis revealed the mosquitoes to frequently feed on acacia plants (~ 89%) (mainly Vachellia tortilis) in the family Fabaceae. Chemical analysis revealed 1-octen-3-ol (29.9%) as the dominant mosquito attractant, and the sugars glucose, sucrose, fructose, talose and inositol enriched in the vegetative parts, of acacia plants. Nutritional analysis of An. longipalpis C with high plant feeding rates detected fewer sugars (glucose, talose, fructose) compared to acacia plants. These results demonstrate (i) the sensitivity of DNA barcoding to detect plant feeding in malaria vectors, (ii) Plasmodium infection status affects energetic reserves of wild anopheline vectors and (iii) nutrient content and olfactory cues likely represent potent correlates of acacia preferred as a host plant by diverse malaria vectors. The results have relevance in the development of odor-bait control strategies including attractive targeted sugar-baits.


Sujet(s)
Anopheles , Codage à barres de l'ADN pour la taxonomie , Écosystème , Vecteurs moustiques , Plasmodium falciparum , Animaux , Vecteurs moustiques/parasitologie , Vecteurs moustiques/génétique , Anopheles/parasitologie , Anopheles/génétique , Anopheles/métabolisme , Kenya , Plasmodium falciparum/génétique , Plasmodium falciparum/métabolisme , Paludisme/transmission , Paludisme/parasitologie , Acacia/métabolisme , Acacia/parasitologie , Acacia/génétique , Comportement alimentaire/physiologie , Ribulose bisphosphate carboxylase/métabolisme , Ribulose bisphosphate carboxylase/génétique
14.
Sci Rep ; 14(1): 20538, 2024 09 04.
Article de Anglais | MEDLINE | ID: mdl-39232052

RÉSUMÉ

This study aimed to develop a predictive tool for surgical site infections (SSI) following hysterectomy and propose strategies for their prevention and control. We conducted a retrospective analysis at a tertiary maternity and child specialist hospital in Zhejiang Province, focusing on patients who underwent hysterectomy between January 2018 and December 2023 for gynecological malignancies or benign reproductive system diseases resistant to medical treatment. Risk factors associated with surgical site infections (SSI) following hysterectomy were identified using LASSO regression analysis on data from 2018 to 2022 as the training set. Independent risk factors were then used to develop a nomogram. The model was validated using data from 2023 as the validation set. Model performance was assessed using the area under the receiver operating characteristic curve (ROC), while calibration curves were employed to gauge model accuracy. Furthermore, clinical utility was evaluated through clinical decision curve analysis (DCA) and clinical impact curve analysis (CIC), providing insights into the practical application of the nomogram. Multivariate analysis identified six independent risk factors associated with SSI development after hysterectomy: BMI ≥ 24 kg/m2 (OR: 2.58; 95% CI 1.14-6.19; P < 0.05), hypoproteinaemia diagnosis (OR: 4.99; 95% CI 1.95-13.02; P < 0.05), postoperative antibiotic use for ≥ 3 days (OR: 49.53; 95% CI 9.73-91.01; P < 0.05), history of previous abdominal surgery (OR: 7.46; 95% CI 2.93-20.01; P < 0.05), hospital stay ≥ 10 days (OR: 9.67; 95% CI 2.06-76.46; P < 0.05), and malignant pathological type (OR: 4.62; 95% CI 1.78-12.76; P < 0.05). A nomogram model was constructed using these variables. ROC and calibration curves demonstrated good model calibration and discrimination in both training and validation sets. Analysis with DCA and CIC confirmed the clinical utility of the nomogram. Personalized nomogram mapping for SSI after hysterectomy enables early identification of high-risk patients, facilitating timely interventions to reduce SSI incidence post-surgery.


Sujet(s)
Hystérectomie , Nomogrammes , Infection de plaie opératoire , Humains , Hystérectomie/effets indésirables , Femelle , Études rétrospectives , Infection de plaie opératoire/diagnostic , Infection de plaie opératoire/étiologie , Infection de plaie opératoire/épidémiologie , Adulte d'âge moyen , Facteurs de risque , Adulte , Courbe ROC , Sujet âgé
15.
Sci Rep ; 14(1): 20607, 2024 09 04.
Article de Anglais | MEDLINE | ID: mdl-39232075

RÉSUMÉ

Biofilm formation and toxin production are some of the virulence factors of Clostridioides difficile (C. difficile), which causes hospital-acquired C. difficile infection (HA-CDI). This work investigated the prevalence and distribution of different strains recovered from HA-CDI patients hospitalized in 4 medical centres across Israel, and characterized strains' virulence factors and antibiotic susceptibility. One-hundred and eighty-eight faecal samples were collected. C. difficile 's toxins were detected by the CerTest Clostridium difficile GDH + Toxin A + B combo card test kit. Toxin loci PaLoc and PaCdt were detected by whole-genome sequencing (WGS). Multi-locus sequence typing (MLST) was performed to classify strains. Biofilm production was assessed by crystal violet. Antibiotic susceptibility was determined using Etest. Fidaxomicin susceptibility was tested via agar dilution. Sequence type (ST) 42 was the most (13.8%) common strain. All strains harboured the 2 toxins genes; 6.9% had the binary toxin. Most isolates were susceptible to metronidazole (98.9%) and vancomycin (99.5%). Eleven (5.85%) isolates were fidaxomicin-resistant. Biofilm production capacity was associated with ST (p < 0.001). In conclusion, a broad variety of C. difficile strains circulate in Israel's medical centres. Further studies are needed to explore the differences and their contribution to HA-CDI epidemiology.


Sujet(s)
Antibactériens , Biofilms , Clostridioides difficile , Infections à Clostridium , Infection croisée , Tests de sensibilité microbienne , Facteurs de virulence , Clostridioides difficile/génétique , Clostridioides difficile/effets des médicaments et des substances chimiques , Clostridioides difficile/isolement et purification , Clostridioides difficile/pathogénicité , Humains , Israël/épidémiologie , Infections à Clostridium/microbiologie , Infections à Clostridium/épidémiologie , Antibactériens/pharmacologie , Facteurs de virulence/génétique , Mâle , Femelle , Biofilms/effets des médicaments et des substances chimiques , Biofilms/croissance et développement , Infection croisée/microbiologie , Infection croisée/épidémiologie , Sujet âgé , Adulte d'âge moyen , Typage par séquençage multilocus , Adulte , Sujet âgé de 80 ans ou plus , Séquençage du génome entier , Fèces/microbiologie
16.
Virol J ; 21(1): 209, 2024 Sep 03.
Article de Anglais | MEDLINE | ID: mdl-39227837

RÉSUMÉ

BACKGROUND: Early pregnancy Zika virus (ZIKV) infection is associated with major brain damage in fetuses, leading to microcephaly in 0.6-5.0% of cases, but the underlying mechanisms remain largely unknown. METHODS: To understand the kinetics of ZIKV infection during fetal development in a nonhuman primate model, four cynomolgus macaque fetuses were exposed in utero through echo-guided intramuscular inoculation with 103 PFU of ZIKV at 70-80 days of gestation, 2 controls were mock inoculated. Clinical, immuno-virological and ultrasound imaging follow-ups of the mother/fetus pairs were performed until autopsy after cesarean section 1 or 2 months after exposure (n = 3 per group). RESULTS: ZIKV was transmitted from the fetus to the mother and then replicate in the peripheral blood of the mother from week 1 to 4 postexposure. Infected fetal brains tended to be smaller than those of controls, but not the femur lengths. High level of viral RNA ws found after the first month in brain tissues and placenta. Thereafter, there was partial control of the virus in the fetus, resulting in a decreased number of infected tissue sections and a decreased viral load. Immune cellular and humoral responses were effectively induced. CONCLUSIONS: ZIKV infection during the second trimester of gestation induces short-term brain injury, and although viral genomes persist in tissues, most of the virus is cleared before delivery.


Sujet(s)
Encéphale , Modèles animaux de maladie humaine , Foetus , Complications infectieuses de la grossesse , Charge virale , Infection par le virus Zika , Virus Zika , Animaux , Femelle , Grossesse , Infection par le virus Zika/virologie , Foetus/virologie , Complications infectieuses de la grossesse/virologie , Encéphale/virologie , Macaca fascicularis/virologie , ARN viral , Placenta/virologie , Transmission verticale de maladie infectieuse
17.
Syst Rev ; 13(1): 224, 2024 Sep 03.
Article de Anglais | MEDLINE | ID: mdl-39227872

RÉSUMÉ

BACKGROUND: Surgical site infections continue to be a significant challenge following colorectal surgery. These can result in extended hospital stays, hospital readmissions, increased treatment costs, and negative effects on patients' quality of life. Antibiotic prophylaxis plays a crucial role in preventing infection during surgery, specifically in preventing surgical site infections after colorectal surgery in adult patients. However, the optimal antibiotic regimen is still unclear based on current evidence. Considering the limitations of existing reviews, our goal is to conduct a comprehensive systematic review and network meta-analysis of randomized controlled trials to evaluate the comparative benefits and harms of available antibiotic prophylaxis regimens for preventing surgical site infections following colorectal surgery in adult patients. METHODS: We will search the Medline, EMBASE, CINAHL, Scopus, and Cochrane Central Register of Controlled Trials databases to identify relevant randomized controlled trials. We will include trials that (1) enrolled adults who underwent colorectal surgeries and (2) randomized them to any systemic administration of antibiotic (single or combined) prophylaxis before surgery compared to an alternative systemic antibiotic (single or combined antibiotic), placebo, control, or no prophylactic treatment. Pairs of reviewers will independently assess the risk of bias among eligible trials using a modified Cochrane risk of bias instrument for randomized trials. Our outcomes of interest include the rate of surgical site infection within 30 days of surgery, hospital length of stay, 30-day mortality, and treatment-related adverse effects. We will perform a contrast-based network meta-analysis using a frequentist random-effects model assuming a common heterogeneity parameter. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach will be utilized to assess the certainty of evidence for treatment effects. DISCUSSION: By synthesizing evidence from available RCTs, this study will provide valuable insight for clinicians, patients, and health policymakers on the most effective antibiotics for preventing surgical site infection. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023434544.


Sujet(s)
Antibioprophylaxie , Méta-analyse en réseau , Essais contrôlés randomisés comme sujet , Infection de plaie opératoire , Humains , Infection de plaie opératoire/prévention et contrôle , Antibioprophylaxie/méthodes , Revues systématiques comme sujet , Antibactériens/usage thérapeutique , Antibactériens/administration et posologie , Chirurgie colorectale/effets indésirables
18.
Crit Care ; 28(1): 293, 2024 Sep 04.
Article de Anglais | MEDLINE | ID: mdl-39227889

RÉSUMÉ

INTRODUCTION: Experimental studies in animals have yielded conflicting results on the role of Tumor Necrosis Factor (TNF) in sepsis and endotoxemia, with some reporting adaptive and others inappropriate effects. A meta-analysis of the available literature was performed to determine the factors explaining this discrepancy. METHODS: The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The protocol was registered with PROSPERO (CRD42020167384) prior to data collection. PubMed and Embase were the databases queried. Risk of bias was evaluated using the SYRCLE Risk of Bias Tool. All animal studies investigating sepsis-related mortality and modified TNF signaling were considered eligible. The exclusion criteria were: lack of mortality data, 7-day mortality rates below 10% in both wild type and TNF-altered pathway animals, and absence of an English abstract. To determine the role of TNF according to the experimental protocol, three approaches were used: first an approach based on the statistical significance of each experiment, then the pooled mortality was calculated, and finally the weighted risk ratio for mortality was assessed. RESULTS: A total of 175 studies were included in the analysis, comprising a total of 760 experiments and involving 19,899 animals. The main species used were mice (77%) and rats (21%). The most common method of TNF pathway modulation was TNF pathway inactivation that was primarily associated with an inappropriate secretion of TNF. At the opposite, TNF injection was associated with an adaptive role of TNF. Lipopolysaccharide (LPS) injection was the most used stimulus to establish an infectious model (42%) and was strongly associated with an inappropriate role of TNF. Conversely, live bacterial models, especially the cecal ligation and puncture (CLP) model, pneumonia, meningitis, and gastrointestinal infection, were associated with an adaptive role. This was particularly evident for Listeria monocytogenes, Streptococcus pneumoniae. CONCLUSION: The role of TNF during infection varies depending on the experimental model used. Models that mimic clinical conditions, based on virulent bacteria that cause high mortality even at low inocula, demonstrated an adaptive role of TNF. Conversely, models based on LPS or low-pathogenic live bacteria, administered at doses well above physiological thresholds and combined with early antibiotic therapy, were associated with an inappropriate role.


Sujet(s)
Sepsie , Facteur de nécrose tumorale alpha , Animaux , Modèles animaux de maladie humaine
19.
Trials ; 25(1): 582, 2024 Sep 03.
Article de Anglais | MEDLINE | ID: mdl-39227966

RÉSUMÉ

INTRODUCTION: Several observational or retrospective studies have previously been conducted to explore the possible association between lung cancer and human papillomavirus (HPV) infection. However, there may be inconsistencies in the data and conclusions due to differences in study design and HPV testing methods. There are currently no studies that provide conclusive evidence to support the involvement of HPV in the occurrence and development of lung cancer. Therefore, the relationship between HPV and lung cancer remains controversial and uncertain. This study aimed to explore whether HPV infection is causally related to lung cancer risk by systematically performing a two-way Two-Sample Mendelian Randomization (TSMR) analysis. METHODS: In the International Lung Cancer Consortium (ILCCO) genome-wide association study dataset, we included 11,348 lung cancer (LUCA) cases, including 3275 squamous cell carcinoma (LUSC) cases, 3442 adenocarcinoma (LUAD) cases, and 15,861 cases of control. Using genetic variants associated with the HPV E7 protein as instrumental variables, we summarized statistics associated with HPV infection in the MRC IEU OpenGWAS database, which included the HPV-16 E7 protein and the HPV-18 E7 protein. Two-sample Mendelian randomization (MR) results are expressed as odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Based on a comprehensive analysis of genome-wide association study (GWAS) data from public databases, we mainly used inverse-variance weighted (IVW) to estimate causal relationships, while using MR-Egger, weighted median, simple mode, and weighted mode, and other four methods as supplements. Two-sample MR Analysis revealed no causal relationship between exposure factors (HPV-16 E7 protein and HPV-18 E7 protein) and outcome factors (lung cancer (LUCA) and its subtypes squamous cell carcinoma (LUSC) and adenocarcinoma (LUAD)) in forward MR Analysis using the IVW approach.HPV-16 E7 protein and LUCA and its subtypes LUSC and LUAD by IVW method results: [OR] = 1.002; 95% [CI]: 0.961 - 1.045; p = 0.920; [OR] = 1.023; 95% [CI]: 0.966 - 1.084; p = 0.438; [OR] = 0.994; 95% [CI]: 0.927 - 1.066; p = 0.872); HPV-18 E7 protein and LUCA and its subtypes LUSC and LUAD by IVW method results: [OR] = 0.965; 95% [CI]: 0.914 - 1.019; p = 0.197; [OR] = 0.933; 95% [CI]: 0.834 - 1.043; p = 0.222; [OR] = 1.028; 95% [CI]: 0.945 - 1.118; p = 0.524. It was observed through reverse MR that LUCA and its subtypes LUSC and LUAD were used as exposure factors, and HPV infection (HPV-16 E7 protein and HPV-18 E7 protein) was used as the outcome factors, the results of the IVW method are also invalid.LUCA and HPV-16 E7 protein and HPV-18 E7 protein by IVW method results: [OR] = 1.036; 95% [CI]: 0.761 - 1.411; p = 0.82; [OR] = 1.318; 95% [CI]: 0.949 - 1.830; p = 0.099; LUSC and HPV-16 E7 protein and HPV-18 E7 protein by IVW method results: [OR] = 1.123; 95% [CI]0.847 - 1.489; p = 0.421; [OR] = 0.931; 95% [CI]: 0.660 - 1.313; p = 0.682; LUAD and HPV-16 E7 protein and HPV-18 E7 protein by IVW method results: [OR] = 1.182; 95% [CI] 0.983 - 1.421; p = 0.075; [OR] = 1.017; 95% [CI]: 0.817 - 1.267; p = 0.877.Our results indicate that there is no causal relationship between genetically predicted HPV infection and LUCA and its subtypes LUSC and LUAD. In addition, in the reverse MR analysis, we did not observe a significant causal relationship between LUCA and its subtypes LUSC and LUAD on HPV infection. CONCLUSIONS: Our findings do not support a genetic association between HPV infection and lung cancer.


Sujet(s)
Étude d'association pangénomique , Tumeurs du poumon , Analyse de randomisation mendélienne , Infections à papillomavirus , Humains , Tumeurs du poumon/génétique , Tumeurs du poumon/virologie , Tumeurs du poumon/épidémiologie , Infections à papillomavirus/virologie , Infections à papillomavirus/génétique , Facteurs de risque , Appréciation des risques , Carcinome épidermoïde/virologie , Carcinome épidermoïde/génétique , Carcinome épidermoïde/épidémiologie , Protéines E7 de papillomavirus/génétique , Prédisposition génétique à une maladie , Adénocarcinome/génétique , Adénocarcinome/virologie , Adénocarcinome/épidémiologie , Papillomavirus humain de type 18/génétique , Adénocarcinome pulmonaire/génétique , Adénocarcinome pulmonaire/virologie , Polymorphisme de nucléotide simple , Phénotype , Virus des Papillomavirus humains
20.
Antimicrob Resist Infect Control ; 13(1): 98, 2024 Sep 04.
Article de Anglais | MEDLINE | ID: mdl-39227975

RÉSUMÉ

BACKGROUND: Gram-negative bacteria resistant to carbapenems are also known as critical antimicrobial resistant organisms. Their emergence at Colonial War Memorial Hospital (CWMH), the largest hospital in Fiji, is a major clinical concern. This study was conducted to determine the knowledge, attitudes, and readiness of healthcare workers (HCW) at CWMH regarding management of patients with infections caused by critical antimicrobial resistant organisms. METHODS: A questionnaire was designed using a Likert scale to assess knowledge, attitudes, and readiness. Two cross-sectional studies were conducted, before and after the implementation of targeted educational activities which were informed by the pre-intervention study findings. RESULTS: A total of 393 and 420 HCW participated in the pre- and post-intervention studies, respectively. The majority of respondents were female (77.3%) and 18-34 years of age (67%). HCW professional roles included nurses (56.3%), doctors (31.6%), and laboratory personnel (12.2%). In the post-intervention study, significantly more HCW reported having received infection prevention and control (IPC) and antimicrobial resistance education and training (26.8% in pre to 45.5% in post intervention, p < 0.001). The majority of nurses and doctors (> 85% to ≥ 95%) were aware of how AMR organisms spread in healthcare settings and knew the IPC measures to prevent transmission of AMR infections including hand hygiene, standard and transmission-based precautions. Attitudes towards AMR were positive, with 84.2% pre intervention and 84.8% of HCW post intervention expressing their willingness to change their work environment to assist with AMR prevention. Perceived readiness to address the problem showed mixed results. Improvements in laboratory AMR surveillance data availability were noted (29.4-52.4%, p < 0001). Modest improvement in the hospital's capacity for outbreak response (44-51.9%, p = 0.01), and treatment of AMR infections (38.9-44.4%, p = 0.01) was reported. CONCLUSIONS: Our data revealed high levels of staff awareness and knowledge about AMR and IPC. However, readiness for outbreak response and treatment of critical AMR infections requires more attention. Improving AMR prevention and containment in CWMH will likely require sustained and multisectoral interventions with strong administrative commitment.


Sujet(s)
Connaissances, attitudes et pratiques en santé , Personnel de santé , Humains , Femelle , Mâle , Fidji , Adulte , Études transversales , Personnel de santé/psychologie , Jeune adulte , Enquêtes et questionnaires , Adolescent , Prévention des infections/méthodes , Adulte d'âge moyen , Infection croisée/microbiologie , Hôpitaux militaires , Attitude du personnel soignant , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Infections bactériennes à Gram négatif
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE